International journal of clinical practice
-
Int. J. Clin. Pract. · Nov 2020
Randomized Controlled Trial Comparative StudyFebuxostat therapy in outpatients with suspected COVID-19: A clinical trial.
The aim of this clinical trial was to evaluate the effects of febuxostat (FBX) in comparison with hydroxychloroquine (HCQ) on clinical symptoms, laboratory tests and chest CT findings in outpatients with moderate symptoms of COVID-19 infection. ⋯ This trial suggests that FBX is as an alternative treatment to HCQ for COVID-19 infection and may be considered in patients with a contraindication or precaution to HCQ.